Table 10Summary of included studies for Comparison 9: Measurement-based care versus standard care

StudyPopulationInterventionComparisonComments

Guo 2015

RCT

China

N=120

Baseline severity: More severe

Mean age (years): 41.1

Sex (% female): 64

Ethnicity (% BME): NR

Measurement-based care

Guideline- and rating scale-based decisions. The treating psychiatrists made treatment decisions about starting dosages, dose adjustments and medication changes of paroxetine (20–60mg/day) or mirtazapine (15–45mg/day), on the basis of ratings on QIDS-SR and the Frequency, Intensity, and Burden of Side Effects Rating scale

Standard care

Duration of programme contact (in months): 3

Outcomes:

  • Depression symptomatology at 6 months
  • Response at 6 months
  • Remission at 6 months
  • Discontinuation at 6 months

BME: black minority ethnic; N: number; NR: not reported; QIDS-SR: quick inventory of depressive symptomatology-self report; RCT: randomised controlled trial; SR: self-report

From: Service delivery Models and settings for delivery of services

Cover of Service delivery Models and settings for delivery of services
Service delivery Models and settings for delivery of services: Depression in adults: Evidence review A.
NICE Guideline, No. 222.
Copyright © NICE 2022.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.